1355049-97-6 Usage
Description
(3R,4R,5R)-4-(benzyloxy)-5-(benzyloxymethyl)-3-fluoro-dihydrofuran-2(3H)-one is an organic compound characterized by its unique molecular structure, featuring a dihydrofuran ring with fluorine substitution at the 3-position and benzyloxy groups at the 4 and 5 positions. (3R,4R,5R)-4-(benzyloxy)-5-(benzyloxymethyl)-3-fluoro-dihydrofuran-2(3H)-one is known for its potential applications in the pharmaceutical industry, particularly in the synthesis of antiviral agents.
Uses
Used in Pharmaceutical Industry:
(3R,4R,5R)-4-(benzyloxy)-5-(benzyloxymethyl)-3-fluoro-dihydrofuran-2(3H)-one is used as a reagent for the preparation of Favipiravir analogues, which are essential in the treatment of influenza. Favipiravir is an antiviral drug that inhibits the replication of the influenza virus, making it a crucial component in managing and treating flu outbreaks.
The compound's unique structure allows it to be a versatile building block in the synthesis of various Favipiravir analogues, potentially leading to the development of more effective antiviral medications. Its use in the pharmaceutical industry highlights the importance of organic chemistry in creating new and improved treatments for viral infections.
Check Digit Verification of cas no
The CAS Registry Mumber 1355049-97-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,5,0,4 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1355049-97:
(9*1)+(8*3)+(7*5)+(6*5)+(5*0)+(4*4)+(3*9)+(2*9)+(1*7)=166
166 % 10 = 6
So 1355049-97-6 is a valid CAS Registry Number.
1355049-97-6Relevant articles and documents
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) Analogues
Wang, Guangyi,Wan, Jinqiao,Hu, Yujian,Wu, Xiangyang,Prhavc, Marija,Dyatkina, Natalia,Rajwanshi, Vivek K.,Smith, David B.,Jekle, Andreas,Kinkade, April,Symons, Julian A.,Jin, Zhinan,Deval, Jerome,Zhang, Qingling,Tam, Yuen,Chanda, Sushmita,Blatt, Lawrence,Beigelman, Leonid
, p. 4611 - 4624 (2016)
Influenza viruses are responsible for seasonal epidemics and occasional pandemics which cause significant morbidity and mortality. Despite available vaccines, only partial protection is achieved. Currently, there are two classes of widely approved anti-in
Compound containing guanidyl group, and preparation method and application thereof
-
Paragraph 0138-0146, (2021/08/07)
The invention provides a preparation containing a guanidino compound and used for treating pneumoviridae virus infection, a method, a compound of a formula I, and a method and an intermediate for synthesizing the compound of the formula I.
METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS
-
Paragraph 0525, (2017/04/04)
Provided are methods for treating Arenaviridae and Coronaviridae virus infections by administering nucleosides and prodrugs thereof, of Formula I: wherein the 1′ position of the nucleoside sugar is substituted. The compounds, compositions, and methods provided are particularly useful for the treatment of Lassa virus and Junin virus infections.